Polarean Imaging PLC
LSE:POLX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cyviz AS
OSE:CYVIZ
|
NO |
|
Gold Cup Electric Apparatus Co Ltd
SZSE:002533
|
CN |
|
Micro Systemation AB (publ)
STO:MSAB B
|
SE |
|
I
|
iSoftStone Information Technology Group Co Ltd
SZSE:301236
|
CN |
Polarean Imaging PLC
EPS (Diluted)
Polarean Imaging PLC
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Polarean Imaging PLC
LSE:POLX
|
EPS (Diluted)
$0
|
CAGR 3-Years
48%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
EPS (Diluted)
$1
|
CAGR 3-Years
63%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
EPS (Diluted)
$1
|
CAGR 3-Years
-9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
Stryker Corp
NYSE:SYK
|
EPS (Diluted)
$8
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
8%
|
|
|
Abbott Laboratories
NYSE:ABT
|
EPS (Diluted)
$3
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
EPS (Diluted)
$7
|
CAGR 3-Years
29%
|
CAGR 5-Years
22%
|
CAGR 10-Years
16%
|
|
Polarean Imaging PLC
Glance View
Polarean Imaging Plc.operates as a medical drug-device combination company serving the medical imaging market in the United States and internationally. The company is headquartered in Durham, North Carolina and currently employs 21 full-time employees. The company went IPO on 2018-03-29. The firm with its subsidiaries operates in the medical imaging market and develops equipment to enable existing magnetic resonance imaging (MRI) systems. The firm develops equipment that enables existing MRI systems to attain an improved level of pulmonary function imaging and specializes in the use of hyperpolarised Xenon gas (129Xe) as an imaging agent to visualize ventilation. 129Xe gas is being studied for visualization of gas exchange regionally in the smallest airways of the lungs, across the alveolar tissue barrier, and into the pulmonary bloodstream. 129Xe used to evaluate pulmonary function and to visualize the lung using MRI. The firm operates in an area of unmet medical need and its technology provides an investigational diagnostic approach, offering a non-invasive and radiation-free functional imaging platform.
See Also
What is Polarean Imaging PLC's EPS (Diluted)?
EPS (Diluted)
-0
USD
Based on the financial report for Jun 30, 2025, Polarean Imaging PLC's EPS (Diluted) amounts to -0 USD.
What is Polarean Imaging PLC's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
28%
Over the last year, the EPS (Diluted) growth was 67%. The average annual EPS (Diluted) growth rates for Polarean Imaging PLC have been 48% over the past three years , 28% over the past five years .
